Skip to main content
OpenTrials
Completed

NCT Number: NCT03446183

Short Term Effect of Smoking Cessation on Human Metabolism

Investigating the short term smoking cessation on metabolism, examining of participant of smoking cessation workshops and former participants' file survey for metabolic aspects

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Smoking Cessation Behavior Glucose Metabolism Disorders Health Behavior Hyperinsulinism Insulin Resistance Metabolic Diseases Metabolic Syndrome Nutritional and Metabolic Diseases

Age range

25 year–70 year

Sex eligibility

All sexes

Study type

Observational

About this study

Objective: To examine metabolic aspects occurring during the first 6-12 months following smoking cessation in participants of smoking cessation workshops.

Design: A two armed study: prospective and retrospective. Prospective: Weight, BMI, waist circumference and waist: hip ratio were measured before, during and 6 months post cessation program. Retrospective: Blood test data for Blood fasting glucose (BFG) and lipid profile from the year preceding the workshops and the year after them were analyzed from participants' files. Smoking status was verified by phone conversation.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Volunteers who were recruited from the smoking cessation workshops of the Meuhedet HMO (Israeli Health Services) during 2016-2017.

Exclusion criteria

  • Candidates with benign tumors, bariatric surgeries, and endoscopic bariatric procedures before or during the study period were excluded

Treatment and study plan

Smoking cessation workshops

Behavioral

All the participants took part in smoking cessation workshops. The comparison of metabolic aspects was made between the smokers and non-smokers

Primary outcomes

  1. Change in weight

    Time frame: 6 months from baseline

    Weight in meters

  2. Change in BMI

    Time frame: 6 months from baseline

    BMI in kg/m2

  3. Change in waist and hip circumference

    Time frame: 6 months from baseline

    Waist and hip curcumference in centimeters

  4. Change in Blood fasting glucose according to patient files (unspecified time points up to a year before and a year after the workshops)

    Time frame: up to 2 years from baseline

    BFG in mg/dl

  5. Change in lipid profile according to patient files (unspecified time points up to a year before and a year after the workshops)

    Time frame: up to 2 years from baseline

    Lipid particle measurements in mg/dl

Sponsors and collaborators

Lead sponsor

Hebrew University of Jerusalem

Other

Collaborators

  • Meuhedet. Healthcare Organization

Registry information

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Feb 26, 2018
Registry last updated
Feb 26, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.